Product NDC: | 13533-603 |
Proprietary Name: | Thrombate III |
Non Proprietary Name: | antithrombin III |
Active Ingredient(s): | & nbsp; antithrombin III |
Administration Route(s): | |
Dosage Form(s): | KIT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 13533-603 |
Labeler Name: | Grifols Therapeutics Inc. |
Product Type: | PLASMA DERIVATIVE |
FDA Application Number: | BLA103196 |
Marketing Category: | BLA |
Start Marketing Date: | 19911230 |
Package NDC: | 13533-603-20 |
Package Description: | 1 KIT in 1 CARTON (13533-603-20) * 10 mL in 1 VIAL, GLASS * 10 mL in 1 VIAL, GLASS |
NDC Code | 13533-603-20 |
Proprietary Name | Thrombate III |
Package Description | 1 KIT in 1 CARTON (13533-603-20) * 10 mL in 1 VIAL, GLASS * 10 mL in 1 VIAL, GLASS |
Product NDC | 13533-603 |
Product Type Name | PLASMA DERIVATIVE |
Non Proprietary Name | antithrombin III |
Dosage Form Name | KIT |
Route Name | |
Start Marketing Date | 19911230 |
Marketing Category Name | BLA |
Labeler Name | Grifols Therapeutics Inc. |
Substance Name | |
Strength Number | |
Strength Unit | |
Pharmaceutical Classes |